VRCA Verrica Pharmaceuticals Inc
Verrica Pharmaceuticals Inc a clinical-stage medical dermatology company focused on identifying, developing and commercializing innovative pharmaceutical products for the treatment of skin diseases with significant unmet needs.
$13.49 +0.15 (1.09%)
As of 03/05/2021 15:59:11 EST IEX book CBOE book
Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Small cap
Health Care
Biotechnology
USA
USA
06/15/2018
25,865,542
87,462
$353,840,615
0.00%
SEC Edgar Online
10-Q
10-K
92511W108
US92511W1080
BZ1NTH2
Common stocks
Small cap
Health Care
Biotechnology
USA
USA
06/15/2018
25,865,542
87,462
$353,840,615
0.00%
SEC Edgar Online
10-Q
10-K
92511W108
US92511W1080
BZ1NTH2
Valuation (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
PB ratio:
PS ratio:
Return on equity:
Net income %:
0.00
9.03
0.00
-129.43%
0.00%
9.03
0.00
-129.43%
0.00%